Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2015).
Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence.
Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Sci. Pharm. 2010, 78(3), 569; https://doi.org/10.3797/scipharm.cespt.8.LNM01 (registering DOI)
Magnetoliposomes: Liposomal Contrast Agents
Institute of Biophysics and Nanosystems Research, Austrian Academy of Sciences, Graz, 8042, Austria
Institute of Medical Engineering, University of Technology, Graz, 8010, Austria
Medical University, Graz, 8010, Austria
Author to whom correspondence should be addressed.
Received: 12 July 2010 / Accepted: 12 July 2010 / Published: 12 July 2010
Abstract Magnetoliposomes (MLs) are phospholipid vesicles encapsulating magnetic nanoparticles utilised as contrast agents for targeted molecular Magnetic Resonance Imaging (MRI). [...]
This is an open access article distributed under the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
FRASCIONE, D.; SABA-LEPEK, M.; DIWOKY, C.; OPRIESSNIG, P.; STOLLBERGER, R.; ALMER, G.; MANGGE, H.; PRASSL, R. Magnetoliposomes: Liposomal Contrast Agents. Sci. Pharm. 2010, 78, 569.
FRASCIONE D, SABA-LEPEK M, DIWOKY C, OPRIESSNIG P, STOLLBERGER R, ALMER G, MANGGE H, PRASSL R. Magnetoliposomes: Liposomal Contrast Agents. Scientia Pharmaceutica. 2010; 78(3):569.
FRASCIONE, D.; SABA-LEPEK, M.; DIWOKY, C.; OPRIESSNIG, P.; STOLLBERGER, R.; ALMER, G.; MANGGE, H.; PRASSL, R. 2010. "Magnetoliposomes: Liposomal Contrast Agents." Sci. Pharm. 78, no. 3: 569.
Show more citation formats
Show less citations formats
[Return to top]
For more information on the journal statistics, click here
Multiple requests from the same IP address are counted as one view.